Fierce Pharma

MARCH 9, 2023

The Top Line': Why pharma needs to ramp up its use of AI and machine learning, plus this week's headlines tcarey Thu, 03/09/2023 - 15:25

93

93

Bio Pharma Dive

SEPTEMBER 8, 2023

Shape uses machine learning and high throughput screening to identify new AAV capsids in ways the company’s CEO compares to the generative AI tools Midjourney and DALLE-2.

Gene Therapy 283

Gene Therapy Gene 283

Scienmag

MARCH 1, 2021

To keep the community up to date, this webinar will focus on an emerging area of high interest to the community-the utilization of automation, AI and Machine learning for fast and smart formulation development, […].

Cosmetics 73

Cosmetics Production Development Engineer 73

BioTech 365

JULY 12, 2021

Veteran AI and ML Leader from LG Electronics and Bosch Joins H1 as SVP of Data Science and Machine Learning Veteran AI and ML Leader from LG Electronics and Bosch Joins H1 as SVP of Data Science and Machine Learning … Continue reading →

40

40

pharmaphorum

APRIL 2, 2024

Explore the innovative use of artificial intelligence (AI) and machine learning (ML) in securing the pharmaceutical supply chain for resilience and safety. Learn how cutting-edge technology is shaping the future of pharmaceutical logistics.

99

99

Pharma Mirror

SEPTEMBER 1, 2023

The integration of artificial intelligence (AI) tools across medical communications is proving to be a transformative development, ushering in increased efficiencies and innovation across the healthcare industry.

Development 130

Development 130

Drug Discovery World

MAY 30, 2024

In this free webinar , hosted by DDW and sponsored by Benchling, you will learn about technology through the lens of artificial intelligence (AI), machine learning and lab automation. Abraham Heifets, CEO at Atomwise will discuss what AI can and can’t do, as well as what AI should and shouldn’t do within drug discovery.

Scientist 52

Scientist Engineer Drugs Production 52

Pharma Mirror

OCTOBER 17, 2022

What is AI? Artificial intelligence (AI) is intelligence demonstrated by machines, as opposed to the natural intelligence displayed by animals including humans. Some Key terms associated with AI Machine learning With a limited need for programming, machines can teach themselves. Deep learning In.

Sales 130

Sales Marketing Research 130

pharmaphorum

FEBRUARY 16, 2024

Explore the role of artificial intelligence and machine learning in drug discovery and the challenges associated with patentability and predictability. Learn how AI is revolutionising the pharmaceutical industry.

Drugs 90

Drugs 90

Drug Discovery World

MAY 20, 2024

In this free webinar, hosted by DDW and sponsored by Benchling, you will learn about technology through the lens of artificial intelligence (AI), machine learning and lab automation. Abraham Heifets, CEO at Atomwise will discuss what AI can and can’t do, as well as what AI should and shouldn’t do within drug discovery.

Scientist 52

Scientist Drugs Production 52

BioSpace

OCTOBER 22, 2023

AI and machine learning could transform drug discovery, but first, practitioners must overcome ethical challenges en route to medicines for all.

Drugs 117

Drugs Development Medicine 117

Pharmaceutical Technology

NOVEMBER 25, 2022

Artificial intelligence (AI) was seen as one of the top current investment priorities and was thought to continue to attract investment in the healthcare sector in the upcoming two years, according to GlobalData's latest report ‘Digital Transformation and Emerging Technology in the Healthcare Industry - 2022 Edition’.

Big Data 363

Big Data Drugs 363

pharmaphorum

APRIL 9, 2024

On today's episode of the podcast CEO and co-founder of 908 Devices Kevin Knopp joins as guest, discussing how such acceleration is by virtue of technological advancements, including the buzzword artificial intelligence (AI) and machine learning when it comes to bioprocessing.

89

89

AuroBlog - Aurous Healthcare Clinical Trials blog

NOVEMBER 6, 2022

Major healthcare and technology companies are looking at exploring the market for artificial intelligence (AI) enabled devices and technologies in the healthcare market in India, according to experts.

Marketing 149

Marketing Clinical Trials Clinical Trials Clinical Research 149

Pharmaceutical Technology

FEBRUARY 17, 2023

Oncology-focused bioinformatics firm M2GEN has entered a multi-year strategic collaboration with Zephyr AI to identify treatments and cures for cancer patients. It will use the machine learning platform from Zephyr AI and a real-world data set (RWD) from M2GEN for creating an oncology discovery product.

Bioinformatics 147

Bioinformatics Production Clinical Trials Clinical Trials 147

Pharma Mirror

SEPTEMBER 15, 2020

The Royal Society of Chemistry has launched its new Text and Data Mining (TDM) solution, making its full collection of research journals available to companies for AI and machine learning applications.

Research 243

Research 243

AuroBlog - Aurous Healthcare Clinical Trials blog

JUNE 20, 2023

Indian pharma scouts for domain expertise in replacement hiring with skills in data analytics, artificial intelligence (AI) & machine learning (ML). A lot of global MNCs, […]

Gene Therapy 141

Gene Therapy Gene Manufacturing Clinical Trials 141

Pharmaceutical Technology

MAY 9, 2023

The deals will add digital chemistry predictive models and further deep learning capabilities to Recursion’s artificial intelligence (AI)-enabled drug discovery platform. Valence will provide deep learning capabilities to Recursion’s drug discovery repertoire. The agreed purchase prices are $40m and $47.5m loss in Q1 2023.

Drugs 130

Drugs Production Research 130

Drug Patent Watch

AUGUST 10, 2023

A recent paper published in the journal “Intelligent Medicine” article discusses various aspects of using AI and machine learning in the pharmaceutical industry for drug discovery and development.

Development 98

Development Drugs Medicine 98

Pharma Mirror

NOVEMBER 29, 2022

As AI technology advances, it is quickly finding its way into the world of healthcare. The rise of machine learning and chatbots in healthcare is moving away from the traditionally doctor-centric model and towards a more patient-centric and automated process built on trust and data. This makes the use of AI somewhat limited.

Doctors 130

Doctors Doctor Regulation 130

BioPharma Reporter

JANUARY 10, 2023

German mRNA pioneer BioNTech will acquire InstaDeep, an artificial intelligence and machine learning specialist, for around Â362m ($439m): pledging to incorporate rapidly evolving AI capabilities into its research, drug discovery, manufacturing and deployment processes.

Manufacturing 133

Manufacturing Drugs Research Development 133

Drug Discovery World

MAY 21, 2024

Ben Holland , CTO and Co-Founder of Antiverse discusses how artificial intelligence and machine learning are benefitting antibody discovery and design. Machine learning emerges as an innovative solution to enhance the antibody discovery process. These biases limit the range of epitopes considered.

Antibody 59

Antibody Development FDA Approval Contract Manufacturing 59

Drug Channels

OCTOBER 22, 2021

Scott discusses the advantages of using artificial intelligence and machine learning to efficiently process reimbursement data and avoid duplicates. Today’s guest post comes from Scott Johnsen, VP of Product at Kalderos.

Drugs 68

Drugs Production 68

STAT News

JANUARY 12, 2023

But medical schools have barely started to teach about AI and machine learning — creating knowledge gaps that could compound the damage caused by flawed algorithms and biased decision-support systems. at the University of Michigan. ” Read the rest…

Research 145

Research 145

Pharmaceutical Technology

DECEMBER 21, 2022

Artificial intelligence (AI) continued to stay in the news with several high-profile deals this year, as the pharmaceutical industry readily took to adopting AI models to improve drug discovery. Across all sectors, AI applications are being used to increase efficiency and reduce costs. Major AI deals in 2022.

Regulation 351

Regulation Pharma Companies Medicine Clinical Trials 351

AuroBlog - Aurous Healthcare Clinical Trials blog

MARCH 15, 2023

Technology adoptions like artificial intelligence and machine learning are bringing in major transformation in the way a primary physician will extend treatment protocols. Some of the medical advances with the technology are genomics and epigenetics, Big Data, AI and ML which are allowing molecular […]

Big Data 100

Big Data Genome Genomics Clinical Trials 100

Pharmaceutical Technology

FEBRUARY 13, 2023

The multimodal approach will combine radiomics analysis of molecular data, medical imaging data, digital pathology, and clinical and biologic data for a comprehensive evaluation of multimodal signatures using AI and machine learning technology.

Genetics 130

Genetics Development Drugs Genome 130

Pharmaceutical Technology

JUNE 16, 2023

Artificial intelligence (AI)-driven commercial optimisation platform provider Verix has purchased start-up.ai for an undisclosed sum, boosting its life science AI capabilities. is a group of AI specialists that helps enterprises improve their processes through AI and machine learning. start-up.ai

Life Science 130

Life Science Engineer Branding Marketing 130

Pharmaceutical Technology

JANUARY 11, 2023

BioNTech has signed an agreement to buy UK-based artificial intelligence (AI) and machine learning (ML)-based products developer InstaDeep in a deal valued at about $440m (£362m) in cash and shares. Our aim is to make BioNTech a technology company where AI is seamlessly integrated into all aspects of our work.”.

Manufacturing 173

Manufacturing Development Vaccination Vaccine 173

Intouch Solutions

JANUARY 19, 2024

Artificial Intelligence (AI) applications have high storage capacity demands that can easily start in the terabyte (a unit of information equal to one million million) range and scale into hundreds of petabytes (1024 terabytes). Regarding prompts, what you give AI is what you get. Same with choosing use cases for AI.

Engineer 105

Engineer Branding Marketing Development 105

Pharmaceutical Technology

JUNE 15, 2023

Artificial intelligence (AI) and other technologies offer a way forward. AI for drug development is rapidly streamlining R&D processes, speeding up time to market and providing a better experience for patients and providers. Explore the opportunities and benefits of AI, and learn how you can improve your drug development process.

Development 130

Development Drugs Clinical Trials Clinical Trials 130

Drug Discovery World

MAY 17, 2024

Deepika Khedekar , Associate Centralized Clinical Trial Lead at IQVIA Inc, looks at the challenges of utilising artificial intelligence (AI) in oncology clinical research. This is where artificial intelligence and machine learning might come handy. Ten million 1 people around the world die from cancer each year.

Trials 59

Trials Clinical Trials Clinical Trials Protein 59

FDA Law Blog

NOVEMBER 29, 2023

Additionally, when models are periodically or continually trained after deployment, there are appropriate controls in place to manage risks of overfitting, unintended bias, or degradation of the model (for example, dataset drift) that may impact the safety and performance of the model as it is used by the Human-AI team.

Development 115

Development Manufacturing Production Regulation 115

Medical Xpress

APRIL 26, 2023

Artificial intelligence and machine learning (AI/ML) technologies are constantly finding new applications across several disciplines. Medicine is no exception, with AI/ML being used for the diagnosis, prognosis, risk assessment, and treatment response assessment of various diseases.

Medicine 92

Medicine Development 92

Drug Discovery World

JUNE 2, 2023

This 28-page eBook, sponsored by Benchling, examines the ways in which artificial intelligence and machine learning are expediting drug discovery efforts. The post Latest eBook: AI and drug development appeared first on Drug Discovery World (DDW).

Development 52

Development Drugs Research 52

Outsourcing Pharma

JUNE 14, 2023

CluePoints is continuing to invest in artificial intelligence (AI) and machine learning (ML) they say they want to help clients 'extract every drop of potential from the RBQM-driven interrogation of their own datasets'. It says it recognizes the importance of educating the industry on the value of this approach.

Regulation 82

Regulation Marketing 82

Drug Discovery World

FEBRUARY 12, 2024

Here, experts weigh in on the impact of artificial intelligence (AI), machine learning (ML) and automation in the sector. While this automation is necessary, there is hesitation to implement technologies and tools such as generative AI and ML. This is part of a series of predictions based on different themes.

Genome 139

Genome Genomics Life Science Gene Therapy 139